Raltegravir potassium is an antiretroviral medication belonging to the integrase strand transfer inhibitor class, primarily used in combination therapy for the treatment of HIV-1 infection by preventing… Read more









Raltegravir potassium is an antiretroviral medication belonging to the integrase strand transfer inhibitor class, primarily used in combination therapy for the treatment of HIV-1 infection by preventing the integration of viral DNA into host cell genomic DNA. To support the rigorous analytical testing and quality control of this active pharmaceutical ingredient, laboratories require high-quality reference standards. This collection includes the API alongside its relevant pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds. These materials are essential for accurate impurity profiling, method development, and validation, ensuring that researchers and quality assurance teams can reliably identify and quantify process-related impurities or degradation products. Utilizing these standardized compounds allows for precise stability testing and regulatory compliance throughout the drug development lifecycle and manufacturing process.